These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. CYPlebrity: Machine learning models for the prediction of inhibitors of cytochrome P450 enzymes. Plonka W; Stork C; Šícho M; Kirchmair J Bioorg Med Chem; 2021 Sep; 46():116388. PubMed ID: 34488021 [TBL] [Abstract][Full Text] [Related]
6. Effects of obesity on the cytochrome P450 enzyme system. Kotlyar M; Carson SW Int J Clin Pharmacol Ther; 1999 Jan; 37(1):8-19. PubMed ID: 10027478 [TBL] [Abstract][Full Text] [Related]
7. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches. Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282 [TBL] [Abstract][Full Text] [Related]
8. Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network. Li X; Xu Y; Lai L; Pei J Mol Pharm; 2018 Oct; 15(10):4336-4345. PubMed ID: 29775322 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of liposomal curcumin cytochrome p450 metabolism. Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001 [TBL] [Abstract][Full Text] [Related]
10. Metabolite profiling and evaluation of CYP450 interaction potential of 'Trimada'- an Ayurvedic formulation. Kar A; Mukherjee PK; Saha S; Banerjee S; Goswami D; Matsabisa MG; Charoensub R; Duangyod T J Ethnopharmacol; 2021 Feb; 266():113457. PubMed ID: 33039629 [TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes. Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Tetrahydropalmatine Enantiomers on the Activity of Five Cytochrome P450 Isozymes in Rats Using a Liquid Chromatography / Mass Spectrometric Method and a Cocktail Approach. Li W; Zhao L; Le J; Zhang Y; Liu Y; Zhang G; Chai Y; Hong Z Chirality; 2015 Aug; 27(8):551-6. PubMed ID: 26032585 [TBL] [Abstract][Full Text] [Related]
13. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1. Bu HZ; Magis L; Knuth K; Teitelbaum P Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532 [TBL] [Abstract][Full Text] [Related]
14. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers. Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of herb-drug interaction of a polyherbal Ayurvedic formulation through high throughput cytochrome P450 enzyme inhibition assay. Pandit S; Kanjilal S; Awasthi A; Chaudhary A; Banerjee D; Bhatt BN; Narwaria A; Singh R; Dutta K; Jaggi M; Singh AT; Sharma N; Katiyar CK J Ethnopharmacol; 2017 Feb; 197():165-172. PubMed ID: 27457692 [TBL] [Abstract][Full Text] [Related]
18. CYPstrate: A Set of Machine Learning Models for the Accurate Classification of Cytochrome P450 Enzyme Substrates and Non-Substrates. Holmer M; de Bruyn Kops C; Stork C; Kirchmair J Molecules; 2021 Aug; 26(15):. PubMed ID: 34361831 [TBL] [Abstract][Full Text] [Related]
19. [Computational Pharmacological Study on Clopidogrel Metabolism Enzymes Influenced by Fufang Danshen Dripping Pill]. Ma ST; Dai GL; Bi XL; Gong MR; Sun BT; Ju WZ; Tan HS Zhong Yao Cai; 2015 May; 38(5):1009-12. PubMed ID: 26767297 [TBL] [Abstract][Full Text] [Related]
20. A comparative study of the CYP450 inhibition potential of marketed drugs using two fluorescence based assay platforms routinely used in the pharmaceutical industry. Kajbaf M; Longhi R; Montanari D; Vinco F; Rigo M; Fontana S; Read KD Drug Metab Lett; 2011 Jan; 5(1):30-9. PubMed ID: 21198439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]